For Blood Cancer Awareness Month, Dr. Guenther Koehne shares why immunotherapy is making this a promising time for people with blood cancers.
|Articles|October 1, 2014
The Ongoing Mammography Debate: Does Routine Screening Matter?
Patrick Borgen, MD, discusses the benefits of early detection versus overtreatment of breast cancer associated with routine breast cancer screening.
Advertisement
Patrick Borgen, MD, discusses the benefits of early detection versus overtreatment of breast cancer associated with regular breast cancer screening.
Advertisement
Related to this article
In the latest installment of CURE's "Text a Survivor" series, Brad Moore answers some of the most common questions people have about living with and beyond a colorectal cancer diagnosis.
Researchers are studying whether combining CAR-T cell therapy with targeted drugs could help children with high-risk leukemia, including infants whose cancer may be more likely to return after treatment.
Advertisement
Advertisement
Trending on CURE
1
Could a Genomic Test Spare You Extra Years of Hormone Therapy?
2
My Sister and I Share a BRCA2 Mutation. We Didn’t Make the Same Choices
3
I’m Jealous of the World — and Grateful I Got to Be Part of It
4
We Eat Bagels Before Cancer Treatment. Here’s Why.
5